RANTES gene single nucleotide polymorphisms and expression in patients with chronic hepatitis B virus infection

Chinese Medical Journal

Volumn 118, Issue 11, 2005, Pages 909-914

  Duan, Zhong Ping ^a   Zhao, Xiu Ying ^b   Huang, De Zhuang ^a   He, Li Xiang ^a   Chen, Yu ^a   Zhao, Chun Hui ^a   Zheng, Bo Jian ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatitis B virus; Infection; Polymorphism; RANTES gene

Indexed keywords

ALPHA INTERFERON; HEPATITIS B(E) ANTIGEN; RANTES;

ALLELE; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RANTES GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION;

ALLELES; GENOTYPE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; POLYMORPHISM, SINGLE NUCLEOTIDE; RANTES;

EID: 20944442464     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. + T cells. Science 1995;270:1811-1815.
2. Moriuchi H, Moriuchi M, Fauci AS. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 1997;158:3483-3491.
3. Zhao XY, Lee SS, Wong KH, et al. A novel CCR5 mutation selectively affects immunoreactivity and fusogenic property of the HIV co-receptor. AIDS 2004; 18:1729-1732.
4. Carrington M, Dean M, Martin MP, et al. Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. Hum Mol Genet 1999;8:1939-1945.
5. Paxton WA, Dragic T, Koup RA, et al. The beta-chemokines, HIV type 1 second receptors, and exposed uninfected persons. AIDS Res Hum Retroviruses 1996;12:1203-1207.
6. Furci L, Scarlatti G, Burastero S, et al. Antigen -driven C-C chemokine-mediated HIV-1 suppression by CD4 (+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J Exp Med 1997;186:455-460.
7. Zhao XY, Lee SS, Wong KH, et al. Effects of single nucleotide polymorphisms in the RANTES promoter region in healthy and HIV-infected indigenous Chinese. Eur J Immunogenet 2004;31:179-83.
8. Kusano F, Tanaka Y, Marumo F, et al. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest 2000;80:415-422.
9. Soo HM, Garzino-Demo A, Hong W, et al. Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. Virology 2002;303:253-277.
10. Xiang J, George SL, Wunschmann S, et al. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 2004;363:2040-2046.
11. Pawlak K, Pawlak D, Mysliwiec M. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients. Cytokine 2004;28:197-204.
12. Liu H, Chao D, Nakayama EE, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 1999;96:4581-4585.
13. An P, Nelson GW, Wang L, et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A 2002;99:10002-10007.
14. Hellier S, Frodsham AJ, Hennig BJ, et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 2003;38:1468-1476.
15. Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Hepatology, Chinese Medical Association Guideline for prevention and therapy of viral hepatitis. Chin J Infect Dis (Chin) 2001;19:56-62.
16. Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004;38S:158-168.
17. Mateescu RB, Rimbas M, Voiosu R. The immunopathogenesis of viral hepatitis. Rom J Intern Med 2004;42:59-67.
18. Zhang PA, Li Y, Xu P, et al. Polymorphisms of interleukin-1B and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B. World J Gastroenterol 2004;10:1826-1829.
19. Yu H, Zhu QR, Gu SQ, et al. Association of interferon-gamma + 874 gene single nucleotide polymorphism with susceptibility to intrauterine HBV infection. Chin J Pediatr (Chin) 2004;42:421-423.
20. Mommeja-Marin H, Mondou E, Blum MR, et al. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 2003;37:1309-1319.
21. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
22. Josse C, Boelaert JR, Best-Belpomme M, et al. Importance of post-transcriptional regulation of chemokine genes by oxidative stress. Biochem J 2001; 360:321-333.